Bridge City Capital’s iRadimed IRMD Stock Holding History

Bridge City Capital’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.79M	Sell	71,043 -1,530	-2%	-$139K	1.55%	22
2026 Q1	$6.99M	Buy	72,573 +1,719	+2%	+$172K	1.94%	12
2025 Q4	$6.89M	Buy	70,854 +11,509	+19%	+$987K	2.03%	7
2025 Q3	$4.22M	Sell	59,345 -833	-1%	-$55.5K	1.13%	30
2025 Q2	$3.6M	Sell	60,178 -978	-2%	-$53.6K	1.01%	34
2025 Q1	$3.21M	Sell	61,156 -743	-1%	-$41.7K	0.96%	46
2024 Q4	$3.4M	Buy	61,899 +462	+0.8%	+$24.3K	0.91%	46
2024 Q3	$3.09M	Buy	61,437 +7,106	+13%	+$328K	0.85%	50
2024 Q2	$2.39M	Buy	54,331 +12,148	+29%	+$517K	0.8%	51
2024 Q1	$1.86M	Buy	42,183 +8,034	+24%	+$355K	0.68%	76
2023 Q4	$1.62M	Buy	34,149 +5,977	+21%	+$251K	0.63%	76
2023 Q3	$1.25M	Buy	+28,172	New	+$1.31M	0.63%	76

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bridge City Capital's IRMD Position: Q2 2026 in Review

Bridge City Capital reduced its iRadimed (IRMD) stake by 2.1% in Q2 2026, selling an estimated $139K and leaving 71,043 shares worth $6.79M. The position accounts for 1.55% of the portfolio, ranked #22.

Bridge City Capital first reported a position in IRMD in Q3 2023 and has held it in 12 quarters since. The position peaked at $6.99M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Bridge City Capital held 71,043 shares of iRadimed worth $6.79M as of Q2 2026.
Bridge City Capital sold 1,530 iRadimed shares in Q2 2026, an estimated $139K.
iRadimed made up 1.55% of Bridge City Capital's portfolio in Q2 2026, its #22 holding.
Bridge City Capital first reported a position in iRadimed in Q3 2023 and has held it in 12 quarters since.
Bridge City Capital's iRadimed position peaked at $6.99M in Q1 2026.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Bridge City Capital's 13F filing for Q2 2026, filed 11 Aug 2026.